IMMray™ PanCan-d detects 98% of pancreatic cancers in retrospective study with 1400 blood samples

Immunovia awarded 2016 Stars of Innovation Prize
of the 4th European Small and Mid-Cap Awards

Read More

Find the answers of a generation in a single drop of blood

We went through the work of a generation of researchers, mapping the immune system response to cancer, molecule by molecule. We pinned down a combination of 25 clinically relevant markers for successful early stage diagnosis of pancreatic cancer. Using antibodies on a single multiplex chip, we measure them all in one go. All you have to do is to apply a drop of blood.

MOVIE
Immunovia and
IMMray™ technology
(10 min)

Immunovia AB first trading day on Nasdaq First North

Immunovia AB first trading day on Nasdaq First North